BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7914787)

  • 1. Comparison of cholecystokinin metabolism by membrane preparations from the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
    Medeiros Mdos S; Turner AJ
    Neurochem Int; 1994 Apr; 24(4):369-77. PubMed ID: 7914787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis of atrial and brain natriuretic peptides by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
    Medeiros Mdos S; Balmforth AJ; Vaughan PF; Turner AJ
    Neuroendocrinology; 1991 Sep; 54(3):295-302. PubMed ID: 1682834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolysis of cholecystokinin by the human astrocytoma clone D384 and the neuroblastoma line SH-SY5Y.
    Medeiros Mdos S; Turner AJ
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):247S. PubMed ID: 8224401
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin-converting enzyme, enkephalinase A and aminopeptidases in the breakdown of enkephalin--studies in cell cultures.
    Lentzen H; Reinsch I; Linke J
    Clin Exp Hypertens A; 1984; 6(10-11):1829-32. PubMed ID: 6099767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK-8).
    Matsas R; Turner AJ; Kenny AJ
    FEBS Lett; 1984 Sep; 175(1):124-8. PubMed ID: 6090206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.
    Dubreuil P; Fulcrand P; Rodriguez M; Fulcrand H; Laur J; Martinez J
    Biochem J; 1989 Aug; 262(1):125-30. PubMed ID: 2554881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of endothelin-converting enzyme in both neuroblastoma and glial cell lines and its localization in rat hippocampus.
    Barnes K; Walkden BJ; Wilkinson TC; Turner AJ
    J Neurochem; 1997 Feb; 68(2):570-7. PubMed ID: 9003042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
    Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
    Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enkephalin degradation by enkephalinergic neuroblastoma cells. Involvement of angiotensin-converting-enzyme.
    Palenker J; Lentzen H; Brandt U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):214-7. PubMed ID: 6328331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'.
    Deschodt-Lanckman M; Strosberg AD
    FEBS Lett; 1983 Feb; 152(1):109-13. PubMed ID: 6132834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slices.
    Camus A; Rose C; Schwartz JC
    Neuroscience; 1989; 29(3):595-602. PubMed ID: 2662053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11.
    Medeiros MD; Turner AJ
    Endocrinology; 1994 May; 134(5):2088-94. PubMed ID: 7908871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.
    Rose C; Camus A; Schwartz JC
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8326-30. PubMed ID: 3186727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
    Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
    Konkoy CS; Davis TP
    J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes.
    Warburton MJ; Bernardini F
    Neurosci Lett; 2002 Oct; 331(2):99-102. PubMed ID: 12361850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of neutral endopeptidase and angiotensin-converting enzyme activity of SK-N-SH cells in vitro by quercetin and resveratrol.
    Melzig MF; Escher F
    Pharmazie; 2002 Aug; 57(8):556-8. PubMed ID: 12227197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues.
    Allred AJ; Diz DI; Ferrario CM; Chappell MC
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F841-50. PubMed ID: 11053044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
    Barrett RW; Steffey ME; Wolfram CA
    Mol Pharmacol; 1989 Apr; 35(4):394-400. PubMed ID: 2539554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.
    Lallement JC; Oiry C; Lima-Leite AC; Lignon MF; Fulcrand P; Galleyrand JC; Martinez J
    Eur J Pharmacol; 1995 Jul; 290(2):61-7. PubMed ID: 8575534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.